| mRNA |
Epothilone B |
FIMM |
pan-cancer |
AAC |
-0.36 |
0.03 |
| mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.29 |
0.06 |
| mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
0.06 |
| mRNA |
MS-275 |
FIMM |
pan-cancer |
AAC |
-0.19 |
0.1 |
| mRNA |
paclitaxel |
FIMM |
pan-cancer |
AAC |
-0.19 |
0.2 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
| mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
-0.15 |
0.3 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |